Waterloo applies nanotechnology to targeted therapies, CO2 conversion and quantum sensors
Researchers at the University of Waterloo are deploying nanotechnology across medicine, green chemical production and quantum materials. Key highlights: nanoscale carriers enabling non‑invasive delivery to retina and brain, metal-nanoparticle electrocatalysts to convert CO2 and make hydrogen peroxide, and 2D quantum materials for compact broadband photodetectors.
The University of Waterloo’s Faculty of Science is translating nanoscale design into tangible applications. Dr. Marianna Foldvari’s group develops nanoscale carriers to deliver drugs, biologics, vaccines and gene therapies via skin, eye and intranasal routes, including delivery of neuroprotective genes to the retina and efficient intranasal transport to the brain. Dr. Anna Klinkova’s lab engineers metal nanoparticles as electrocatalysts to drive CO2 conversion into fuels and to produce hydrogen peroxide on demand. Dr. Adam Wei Tsen’s team at the Institute for Quantum Computing explores two‑dimensional quantum materials for compact, high‑performance light sensors.
Read the original story · Université de Waterloo — nouvelles ↗